인도네시아 보건부로부터 IDMasDR의 의료기기 허가를 취득하였습니다.  

베트남 당뇨 환자의 실명 위기, K바이오가 막았다 https://biz.chosun.com/science-chosun/medicine-health/2025/06/23/M3KXYPWXUVCONI66OHZIYMWTV4/

외국인 직원 실명 위기서 구해…수술비 지원해준 '이 회사' https://n.news.naver.com/article/015/0005148829?sid=101  

'iDMasDR 홍보 영상'은 첨부파일을 확인해주세요.    

벤처기업확인서를 갱신하였습니다.  

MOU signing ceremony (RetiMark, Dong Nai General Hospital, Chang Shin Vietnam, SNUBH, Singapore National Eye Centre)   A memorandum of understanding was signed to cooperate on disease diagnosis and treatment for workers. At the signing ceremony, the management of Changshin Vietnam Co., Ltd. announced that the company cooperated with RetiMark Co., Ltd. to provide digital technology medical equipment to test and screen workers at risk of the disease to support the treatment of diabetic retinopathy. The signing of the memorandum of understanding with Dong Nai General Hospital is a meaningful activity to provide better health care not only to employees but also to local residents and the community.   https://baodongnai.com.vn/xa-hoi/202411/cong-ty-tnhh-changshin-viet-..

RetiMark attended the 2024 SWITCH.   Thank you to everyone for your participation and interest.          

Eye researchers in Singapore secure second $25 million grant to prevent vision loss caused by age-related macular degeneration among Asians - Singapore National Eye Centre (snec.com.sg)   Another $25m for research to fight eye disease that affects up to one in 10 seniors | The Straits Times   本地眼科团队再获2500万元经费 研究老年黄斑病变 | 联合早报 (zaobao.com.sg)   위 연구에 레티마크도 공동으로 참여할 예정입니다.  

International Symposium on The Next-generation Medical Technologies for Diabetes and Diabetic Retinopathy 당뇨병 및 당뇨망막병증에 대한 차세대 의료 기술에 관한 국제 심포지엄                  

호주 특허청으로부터 'Combination maker for diagnosis of diabetic retinopathy and use thereof'에 대한 특허를 취득하였습니다.